| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |